Results 1 to 9 of about 17 (9)

Field Observations During the Third Microwave Water and Energy Balance Experiment (MicroWEX-3): June 16 - December 21, 2004

open access: yesEDIS, 2019
The goal of MicroWEX-3 was to understand the land-atmosphere interactions during the growing season of cotton, and their effect on observed microwave brightness signatures at 6.7 GHz, matching that of the two satellite-based microwave radiometers (AMSR ...
Tzu-yun Lin   +7 more
doaj   +9 more sources

Análisis de la diversidad genética y caracterización del genoma mitocondrial completo del “churo gigante” Pomacea reevei Ampuero & Ramírez 2023 (Mollusca: Ampullariidae) de la Amazonía Peruana [PDF]

open access: yes, 2023
Evalúa la diversidad genética poblacional del "churo gigante" Pomacea reevei en base a secuencias de COX1, 16S rRNA y marcadores ISSR, sugiriendo que esta especie posee una diversidad genética extremadamente baja.
Mendivil Malpica, Alejandro
core  

Performance of Small-Fruited Pumpkin Cultivars in Maine [PDF]

open access: yes, 2009
A small-fruited (2-4 lb) or “pie” type pumpkin variety trial was established in the spring of 2009 at Highmoor Farm in Monmouth, ME. Three replications of seven varieties were direct-seeded on 18 June through black plastic mulch.
Handley, David T.   +2 more
core   +1 more source

Role of type IV secretion systems in trafficking of virulence determinants of Burkholderia cenocepacia [PDF]

open access: yes, 2009
Type IV secretion systems have been identified in several human pathogens including Bordetella pertussis, Helicobacter pylori, and Legionella pneumophila.
Engledow, Amanda Suzanne
core   +1 more source

Evolution et spécialisation du pouvoir pathogène de Xanthomonas citri pv. citri : rôle des effecteurs de type 3 [PDF]

open access: yes, 2013
La spécialisation d'hôtes est une forme d'adaptation où l'agent pathogène est essentiellement capable d'attaquer un seul hôte ou une gamme d'hôtes relativement restreinte.
Escalon, Aline
core  

Immunogenicity and safety of DS-5670d, an omicron XBB.1.5-targeting COVID-19 mRNA vaccine: A phase 3, randomized, active-controlled study. [PDF]

open access: yesPLoS Med
Kawamoto A   +8 more
europepmc   +1 more source
Home - About - Disclaimer - Privacy